Ausgabe 3/2019
Inhalt (18 Artikel)
Extending Life in Duchenne Muscular Dystrophy: Implications for Appraisals of Cost-Effectiveness
Erik Landfeldt
Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK
Yaling Yang, Lucy Abel, James Buchanan, Thomas Fanshawe, Bethany Shinkins
Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Nigel Fleeman, Adrian Bagust, Rui Duarte, Marty Richardson, Sarah Nevitt, Angela Boland, Eleanor Kotas, Joanne McEntee, Nicky Thorp
Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing
Sabine Vogler, Peter Schneider, Nina Zimmermann
The Worth of a Quality-Adjusted Life-Year in Patients with Diabetes: An Investigation Study using a Willingness-to-Pay Method
Najme Moradi, Arash Rashidian, Shirin Nosratnejad, Alireza Olyaeemanesh, Marzieh Zanganeh, Leila Zarei
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada
Peter L. Quon, Ying Xiao, Sonja Sorensen, Amir Abbas Tahami Monfared
Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study
Luis Manuel Entrenas Costa, Francisco Casas-Maldonado, José Gregorio Soto Campos, Alicia Padilla-Galo, Alberto Levy, Francisco Javier Álvarez Gutiérrez, Ana P. Gómez-Bastero Fernández, Concepción Morales-García, Rocío Gallego Domínguez, Gustavo Villegas Sánchez, Luis Mateos Caballero, Antonio Pereira-Vega, Cayo García Polo, Gerardo Pérez Chica, Juan José Martín Villasclaras
Estimated Versus Observed Expenditure Associated with Medicines Recommended by the All Wales Medicines Strategy Group
Stuart Keeping, Paul N. Deslandes, Kathryn E. Haines, Philip A. Routledge
The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q
Dawn Lee, Nic Brereton, Sujith Dhanasiri, Austin Kulasekararaj
Remote Monitoring of Patient-Reported Outcomes in Ulcerative Colitis: A Prospective Real-World Pilot Study
Shaji Sebastian, Jenna Roberts, John Waller, Davneet Judge, Chloe Brown, Ruth Davies, Sumesh Kachroo
Associations between Health-Related Quality of Life and Self-Reported Emergency Room Department Visits and Inpatient Hospitalizations: Insights from a Secondary Data Analysis of Patients with Light-Chain (AL) Amyloidosis
Kristen L. McCausland, Avery A. Rizio, Michelle K. White, Martha S. Bayliss, Tiffany P. Quock
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
Ash Bullement, Paul Nathan, Anna Willis, Amerah Amin, Cameron Lilley, Ceilidh Stapelkamp, Anthony Hatswell, Chris Pescott, Murtuza Bharmal
Cost of Treatment of Valvular Heart Disease at a Tertiary Hospital in North India: Policy Implications
Shankar Prinja, Yashpaul Sharma, Jyoti Dixit, Shyam Kumar Singh Thingnam, Rajesh Kumar
A Review of Issues Affecting the Efficiency of Decision Making in the NICE Single Technology Appraisal Process
M. J. Walton, J. O’Connor, C. Carroll, L. Claxton, R. Hodgson
Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials
Joshua K. Porter, Gian Luca Di Tanna, Richard B. Lipton, Sandhya Sapra, Guillermo Villa
All-Male Panels and Gender Diversity of Issue Panels and Plenary Sessions at ISPOR Europe
Jacoline C. Bouvy, Michelle Mujoomdar
All Male Panels and Other Diversity Considerations for ISPOR
Nancy J. Devlin
Correction to: Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations
Jing Shen, Sarah Hill, David Mott, Matthew Breckons, Luke Vale, Rob Pickard